Status:

COMPLETED

Ascorbic Acid Treatment in CMT1A Trial (AATIC)

Lead Sponsor:

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Conditions:

Charcot-Marie-Tooth Disease

Hereditary Motor and Sensory Neuropathies

Eligibility:

All Genders

12-25 years

Phase:

PHASE2

Brief Summary

Charcot-Marie-Tooth type IA (CMT1A) is the most prevalent hereditary peripheral neuropathy. Demyelination of peripheral nerves is the hallmark of CMT1A. Ascorbic acid has been shown to have a favorabl...

Detailed Description

Charcot-Marie-Tooth type 1A (CMT1A), or hereditary motor and sensory neuropathy type Ia (HMSN Ia), is an autosomal dominant disease, most often caused by a 1.5 Mb duplication of chromosome 17, giving ...

Eligibility Criteria

Inclusion

  • DNA-proven CMT1A patients
  • Age 12-25 years
  • CMT 1A patients with symptomatology defined as muscle weakness in at least foot dorsiflexion

Exclusion

  • Due to possible influence on severity of the neuropathy:
  • Known other disease that may cause a neuropathy, that may decrease mobility, or that may lead to severe disability or death in a short time
  • Medication that may cause a neuropathy
  • Chronic alcohol abuse
  • Due to study medication (ascorbic acid):
  • Regular use of vitamin C
  • Clinical or echographic signs of nephrolithiasis
  • Reduced glomerular filtration rate
  • Iron overload
  • No regular dental control at the dentist
  • Pregnancy or active pregnancy wish for women
  • Due to study design and primary outcome:
  • Not signing the informed consent
  • Psychiatric co-morbidity which may influence compliance
  • Not being comfortable during nerve conduction studies of the median nerve
  • A too small CMAP amplitude of the abductor pollicis brevis muscle for a proper determination of the nerve conduction velocity of the median nerve

Key Trial Info

Start Date :

January 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2007

Estimated Enrollment :

13 Patients enrolled

Trial Details

Trial ID

NCT00271635

Start Date

January 1 2006

End Date

July 1 2007

Last Update

July 4 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Neurology Academic Medical Center University of Amsterdam

Amsterdam, P.O.Box 22660, Netherlands, 1100 DD

Ascorbic Acid Treatment in CMT1A Trial (AATIC) | DecenTrialz